World Journal of Dentistry

Register      Login

VOLUME 10 , ISSUE 6 ( November-December, 2019 ) > List of Articles

EDITORIAL

Is it Safe to Use Mesenchymal Stem Cells in Cancer Patients?

Supriya Kheur, Archana A Gupta

Citation Information : Kheur S, Gupta AA. Is it Safe to Use Mesenchymal Stem Cells in Cancer Patients?. World J Dent 2019; 10 (6):407-407.

DOI: 10.5005/jp-journals-10015-1688

License: CC BY-NC 4.0

Published Online: 00-12-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Raj AT, Patil S, Rajkumar C, et al. Assessing the role of immune system in cancer progression from minimal residual disease. Oral Oncol 2017;75:180–181. DOI: 10.1016/j.oraloncology.2017.10.017.
  2. Raj AT, Kheur S. Hypothesizing the potential implications of exposing known carcinogens on normal stem cells. Oral Oncol 2018;79:86–87. DOI: 10.1016/j.oraloncology.2018.02.020.
  3. Raj AT, Kheur S, Bhonde R, et al. Use of bone marrow-derived mesenchymal stem cells in prostate cancer could increase the risk of cancer progression. Stem Cells Transl Med 2019;8(7):737–738. DOI: 10.1002/sctm.19-0050.
  4. Ji X, Zhang Z, Han Y, et al. Mesenchymal stem cells derived from normal gingival tissue inhibit the proliferation of oral cancer cells in vitro and in vivo. Int J Oncol 2016;49(5):2011–2022. DOI: 10.3892/ijo.2016.3715.
  5. Papaccio F, Paino F, Regad T, et al. Concise review: cancer cells, cancer stem cells, and Mesenchymal stem cells: influence in cancer development. Stem Cells Transl Med 2017;6(12):2115–2125. DOI: 10.1002/sctm.17-0138.
  6. Barcellos-de-Souza P, Comito G, Pons-Segura C, et al. Mesenchymal stem cells are recruited and activated into carcinoma-associated fibroblasts by prostate cancer microenvironment-derived TGF-β1. Stem Cells 2016;34(10):2536–2547. DOI: 10.1002/stem.2412.
  7. Schweizer MT, Wang H, Bivalacqua TJ, et al. A phase I study to assess the safety and cancer-homing ability of allogeneic bone marrow-derived mesenchymal stem cells in men with localized prostate cancer. Stem Cells Transl Med 2019;8(5):441–449. DOI: 10.1002/sctm.18-0230.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.